What is abciximab used for?
Abciximab is a prescription antiplatelet medicine used to help prevent blood clots from forming in certain high-risk heart and stent procedures [1].
How does abciximab work?
Abciximab blocks a platelet surface receptor called GPIIb/IIIa. By inhibiting this receptor, it reduces platelet aggregation (clumping), which lowers the chance of clot formation in the coronary arteries [1].
When is abciximab given?
It is used in medical settings tied to acute coronary events and percutaneous coronary intervention (PCI), particularly when clinicians want strong short-term platelet inhibition around the procedure [1].
What are the main safety concerns patients ask about?
The main risks are bleeding-related because the drug reduces the blood’s ability to clot. Other adverse effects can occur, but bleeding is the key concern that determines whether abciximab is appropriate for a given patient [1].
Is abciximab the same as other “GPIIb/IIIa inhibitors”?
Abciximab is in the same drug class as other GPIIb/IIIa inhibitors, but it is distinct from the others by its specific properties and clinical use patterns [1].
Where can I find official information?
For detailed prescribing information, including dosing, contraindications, and monitoring requirements, check the product’s FDA label or equivalent official documentation [1].
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm